These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2425 related articles for article (PubMed ID: 18922242)

  • 1. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological predictors of lithium response in bipolar disorder.
    Ikeda A; Kato T
    Psychiatry Clin Neurosci; 2003 Jun; 57(3):243-50. PubMed ID: 12753562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
    Auxéméry Y
    Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further evidence for a possible association between serotonin transporter gene and lithium prophylaxis in mood disorders.
    Serretti A; Malitas PN; Mandelli L; Lorenzi C; Ploia C; Alevizos B; Nikolaou C; Boufidou F; Christodoulou GN; Smeraldi E
    Pharmacogenomics J; 2004; 4(4):267-73. PubMed ID: 15111989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term lithium prophylaxis in the bipolar affective disorder].
    Suwalska A; Chłopocka-Woźniak M; Rybakowski J
    Psychiatr Pol; 2002; 36(6 Suppl):63-9. PubMed ID: 12647423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prediction of treatment response in acute mania: controlled clinical trials with divalproex].
    Swann AC
    Encephale; 2001; 27(3):277-9. PubMed ID: 11488258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder.
    McQuillin A; Rizig M; Gurling HM
    Pharmacogenet Genomics; 2007 Aug; 17(8):605-17. PubMed ID: 17622937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
    Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
    J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study.
    Severus WE; Kleindienst N; Evoniuk G; Bowden C; Möller HJ; Bohus M; Frangou S; Greil W; Calabrese JR
    J Affect Disord; 2009 Jun; 115(3):466-70. PubMed ID: 19019453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term pharmacological treatment of bipolar disorders.
    Rybakowski J
    Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():71-93. PubMed ID: 17262006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loudness dependence of primary auditory-cortex-evoked activity as predictor of therapeutic outcome to prophylactic lithium treatment in affective disorders--a retrospective study.
    Juckel G; Mavrogiorgou P; Bredemeier S; Gallinat J; Frodl T; Schulz C; Möller HJ; Hegerl U
    Pharmacopsychiatry; 2004 Mar; 37(2):46-51. PubMed ID: 15048610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsants in bipolar disorder.
    Singh V; Muzina DJ; Calabrese JR
    Psychiatr Clin North Am; 2005 Jun; 28(2):301-23. PubMed ID: 15826734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium in the long-term treatment of bipolar disorders.
    Kleindienst N; Greil W
    Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):120-5. PubMed ID: 12904975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Predictors of response to phase prophylactics (mood stabilizers) in bipolar affective disorders].
    Walden J; Normann C; Langosch J; Grunze H
    Fortschr Neurol Psychiatr; 1999 Feb; 67(2):75-80. PubMed ID: 10093780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics of lithium response in bipolar disorder.
    Alda M
    J Psychiatry Neurosci; 1999 Mar; 24(2):154-8. PubMed ID: 10212559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with response to lithium prophylaxis in DSM III major depression and bipolar disorder.
    Maj M; Arena F; Lovero N; Pirozzi R; Kemali D
    Pharmacopsychiatry; 1985 Sep; 18(5):309-13. PubMed ID: 3931108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up.
    Baethge C; Gruschka P; Berghöfer A; Bauer M; Müller-Oerlinghausen B; Bschor T; Smolka MN
    J Affect Disord; 2004 Apr; 79(1-3):43-50. PubMed ID: 15023479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Child and adolescent bipolar disorder].
    Aichhorn W; Stuppäck C; Kralovec K; Yazdi K; Aichhorn M; Hausmann A
    Neuropsychiatr; 2007; 21(2):84-92. PubMed ID: 17640494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of lithium response in affective disorders.
    Ananth J; Pecknold JC
    J Clin Psychiatry; 1978 Feb; 39(2):95-100. PubMed ID: 344305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 122.